Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.0K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.0K
Pharmacokinetics: Overview01:10

Pharmacokinetics: Overview

8.4K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
8.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

131
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

3.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.1K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

114
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
114
Three-Compartment Open Model01:06

Three-Compartment Open Model

724
The three-compartment open model is a pharmacokinetic model used to describe the distribution and elimination of drugs following extravascular administration. It comprises a central compartment representing the plasma and two peripheral compartments. The highly perfused peripheral compartment represents organs and tissues with a rich blood supply, such as the liver, kidneys, and lungs. The scarcely perfused peripheral compartment represents tissues with lower blood supply, such as adipose...
724

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying stakeholder behaviors for competency-based pharmacy education: A stage 1 behavior change wheel analysis.

Research in social & administrative pharmacy : RSAP·2026
Same author

A bibliometric analysis describing the global scope of pharmacist roles (2000-2024).

Journal of the American Pharmacists Association : JAPhA·2026
Same author

2025-2026 Academic Affairs Committee Report: Advancing Competency-Based Pharmacy Education and Academic Coaching.

American journal of pharmaceutical education·2026
Same author

A Bibliometric Analysis of Pharmacist-Delivered Care: Global Trends, Outcomes, and Practice Settings (2000-2024).

Journal of the American College of Clinical Pharmacy : JACCP·2026
Same author

A qualitative analysis of pharmacy educator and recent graduates' perceptions regarding declining NAPLEX first-time pass rates.

Currents in pharmacy teaching & learning·2026
Same author

Future-Proofing Pharmacy: A Stakeholder-Informed Forecast of Workforce and Education Needs.

Journal of the American College of Clinical Pharmacy : JACCP·2026

Related Experiment Video

Updated: Dec 14, 2025

Using Learning Outcome Measures to assess Doctoral Nursing Education
10:07

Using Learning Outcome Measures to assess Doctoral Nursing Education

Published on: June 21, 2010

19.3K

Pharmacy Education Crosses the Rubicon.

Frank Romanelli1,2, Denise H Rhoney3, Esther P Black1

  • 1University of Kentucky, College of Pharmacy, Lexington, Kentucky.

American Journal of Pharmaceutical Education
|July 16, 2020
PubMed
Summary

The COVID-19 pandemic forced rapid changes in academic pharmacy education, particularly in experiential learning. These disruptions are likely to create a lasting "new normal" for pharmacy schools.

Keywords:
academiaeducation

More Related Videos

Purification of the Membrane Compartment for Endoplasmic Reticulum-associated Degradation of Exogenous Antigens in Cross-presentation
12:48

Purification of the Membrane Compartment for Endoplasmic Reticulum-associated Degradation of Exogenous Antigens in Cross-presentation

Published on: August 21, 2017

8.5K
Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology
09:55

Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology

Published on: September 28, 2022

1.9K

Related Experiment Videos

Last Updated: Dec 14, 2025

Using Learning Outcome Measures to assess Doctoral Nursing Education
10:07

Using Learning Outcome Measures to assess Doctoral Nursing Education

Published on: June 21, 2010

19.3K
Purification of the Membrane Compartment for Endoplasmic Reticulum-associated Degradation of Exogenous Antigens in Cross-presentation
12:48

Purification of the Membrane Compartment for Endoplasmic Reticulum-associated Degradation of Exogenous Antigens in Cross-presentation

Published on: August 21, 2017

8.5K
Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology
09:55

Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology

Published on: September 28, 2022

1.9K

Area of Science:

  • Pharmacy Education
  • Higher Education
  • Pandemic Response

Background:

  • The COVID-19 pandemic caused unprecedented societal shifts.
  • Academic institutions, including pharmacy schools, faced significant operational challenges.
  • Traditional educational models required immediate adaptation.

Purpose of the Study:

  • To analyze the impact of the COVID-19 pandemic on academic pharmacy education.
  • To examine the adaptations made in response to pandemic-related disruptions.
  • To assess the potential for a lasting transformation in pharmacy experiential education.

Main Methods:

  • Qualitative analysis of institutional responses to the pandemic.
  • Review of changes implemented in pharmacy curricula and experiential learning.
  • Assessment of the sustainability of pandemic-induced educational innovations.

Main Results:

  • Pharmacy schools rapidly altered teaching and instruction methods.
  • Experiential education components underwent significant mitigation strategies.
  • Substantial resources were dedicated to implementing these educational changes.

Conclusions:

  • The pandemic accelerated necessary changes in pharmacy education.
  • Disruptions have likely established a new, potentially permanent, educational paradigm.
  • A full return to pre-pandemic educational practices in pharmacy is improbable.